Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acromegaly Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Somatostatin Analogues
1.2.3 Dopamine Agonists
1.2.4 Growth Hormone Receptor Antagonists
1.2.5 Other
1.3 Market by Application
1.3.1 Global Acromegaly Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acromegaly Market Perspective (2018-2033)
2.2 Acromegaly Growth Trends by Region
2.2.1 Global Acromegaly Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acromegaly Historic Market Size by Region (2018-2023)
2.2.3 Acromegaly Forecasted Market Size by Region (2024-2033)
2.3 Acromegaly Market Dynamics
2.3.1 Acromegaly Industry Trends
2.3.2 Acromegaly Market Drivers
2.3.3 Acromegaly Market Challenges
2.3.4 Acromegaly Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acromegaly Players by Revenue
3.1.1 Global Top Acromegaly Players by Revenue (2018-2023)
3.1.2 Global Acromegaly Revenue Market Share by Players (2018-2023)
3.2 Global Acromegaly Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acromegaly Revenue
3.4 Global Acromegaly Market Concentration Ratio
3.4.1 Global Acromegaly Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acromegaly Revenue in 2022
3.5 Acromegaly Key Players Head office and Area Served
3.6 Key Players Acromegaly Product Solution and Service
3.7 Date of Enter into Acromegaly Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acromegaly Breakdown Data by Type
4.1 Global Acromegaly Historic Market Size by Type (2018-2023)
4.2 Global Acromegaly Forecasted Market Size by Type (2024-2033)
5 Acromegaly Breakdown Data by Application
5.1 Global Acromegaly Historic Market Size by Application (2018-2023)
5.2 Global Acromegaly Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acromegaly Market Size (2018-2033)
6.2 North America Acromegaly Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acromegaly Market Size by Country (2018-2023)
6.4 North America Acromegaly Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acromegaly Market Size (2018-2033)
7.2 Europe Acromegaly Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acromegaly Market Size by Country (2018-2023)
7.4 Europe Acromegaly Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acromegaly Market Size (2018-2033)
8.2 Asia-Pacific Acromegaly Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acromegaly Market Size by Region (2018-2023)
8.4 Asia-Pacific Acromegaly Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acromegaly Market Size (2018-2033)
9.2 Latin America Acromegaly Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acromegaly Market Size by Country (2018-2023)
9.4 Latin America Acromegaly Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acromegaly Market Size (2018-2033)
10.2 Middle East & Africa Acromegaly Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acromegaly Market Size by Country (2018-2023)
10.4 Middle East & Africa Acromegaly Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Acromegaly Introduction
11.1.4 Novartis Revenue in Acromegaly Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Aegis Therapeutics
11.2.1 Aegis Therapeutics Company Detail
11.2.2 Aegis Therapeutics Business Overview
11.2.3 Aegis Therapeutics Acromegaly Introduction
11.2.4 Aegis Therapeutics Revenue in Acromegaly Business (2018-2023)
11.2.5 Aegis Therapeutics Recent Development
11.3 Chiasma
11.3.1 Chiasma Company Detail
11.3.2 Chiasma Business Overview
11.3.3 Chiasma Acromegaly Introduction
11.3.4 Chiasma Revenue in Acromegaly Business (2018-2023)
11.3.5 Chiasma Recent Development
11.4 Crinetics Pharmaceuticals
11.4.1 Crinetics Pharmaceuticals Company Detail
11.4.2 Crinetics Pharmaceuticals Business Overview
11.4.3 Crinetics Pharmaceuticals Acromegaly Introduction
11.4.4 Crinetics Pharmaceuticals Revenue in Acromegaly Business (2018-2023)
11.4.5 Crinetics Pharmaceuticals Recent Development
11.5 Daewoong Pharmaceutical
11.5.1 Daewoong Pharmaceutical Company Detail
11.5.2 Daewoong Pharmaceutical Business Overview
11.5.3 Daewoong Pharmaceutical Acromegaly Introduction
11.5.4 Daewoong Pharmaceutical Revenue in Acromegaly Business (2018-2023)
11.5.5 Daewoong Pharmaceutical Recent Development
11.6 Peptron
11.6.1 Peptron Company Detail
11.6.2 Peptron Business Overview
11.6.3 Peptron Acromegaly Introduction
11.6.4 Peptron Revenue in Acromegaly Business (2018-2023)
11.6.5 Peptron Recent Development
11.7 Silence Therapeutics
11.7.1 Silence Therapeutics Company Detail
11.7.2 Silence Therapeutics Business Overview
11.7.3 Silence Therapeutics Acromegaly Introduction
11.7.4 Silence Therapeutics Revenue in Acromegaly Business (2018-2023)
11.7.5 Silence Therapeutics Recent Development
11.8 Strongbridge Biopharma
11.8.1 Strongbridge Biopharma Company Detail
11.8.2 Strongbridge Biopharma Business Overview
11.8.3 Strongbridge Biopharma Acromegaly Introduction
11.8.4 Strongbridge Biopharma Revenue in Acromegaly Business (2018-2023)
11.8.5 Strongbridge Biopharma Recent Development
11.9 Amryt Pharma
11.9.1 Amryt Pharma Company Detail
11.9.2 Amryt Pharma Business Overview
11.9.3 Amryt Pharma Acromegaly Introduction
11.9.4 Amryt Pharma Revenue in Acromegaly Business (2018-2023)
11.9.5 Amryt Pharma Recent Development
11.10 Foresee Pharmaceuticals
11.10.1 Foresee Pharmaceuticals Company Detail
11.10.2 Foresee Pharmaceuticals Business Overview
11.10.3 Foresee Pharmaceuticals Acromegaly Introduction
11.10.4 Foresee Pharmaceuticals Revenue in Acromegaly Business (2018-2023)
11.10.5 Foresee Pharmaceuticals Recent Development
11.11 Glide Pharmaceutical
11.11.1 Glide Pharmaceutical Company Detail
11.11.2 Glide Pharmaceutical Business Overview
11.11.3 Glide Pharmaceutical Acromegaly Introduction
11.11.4 Glide Pharmaceutical Revenue in Acromegaly Business (2018-2023)
11.11.5 Glide Pharmaceutical Recent Development
11.12 Ionis Pharmaceuticals
11.12.1 Ionis Pharmaceuticals Company Detail
11.12.2 Ionis Pharmaceuticals Business Overview
11.12.3 Ionis Pharmaceuticals Acromegaly Introduction
11.12.4 Ionis Pharmaceuticals Revenue in Acromegaly Business (2018-2023)
11.12.5 Ionis Pharmaceuticals Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Detail
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Acromegaly Introduction
11.13.4 Ipsen Revenue in Acromegaly Business (2018-2023)
11.13.5 Ipsen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acromegaly Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Somatostatin Analogues
Table 3. Key Players of Dopamine Agonists
Table 4. Key Players of Growth Hormone Receptor Antagonists
Table 5. Key Players of Other
Table 6. Global Acromegaly Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Acromegaly Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Acromegaly Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Acromegaly Market Share by Region (2018-2023)
Table 10. Global Acromegaly Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Acromegaly Market Share by Region (2024-2033)
Table 12. Acromegaly Market Trends
Table 13. Acromegaly Market Drivers
Table 14. Acromegaly Market Challenges
Table 15. Acromegaly Market Restraints
Table 16. Global Acromegaly Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Acromegaly Market Share by Players (2018-2023)
Table 18. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly as of 2022)
Table 19. Ranking of Global Top Acromegaly Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Acromegaly Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acromegaly Product Solution and Service
Table 23. Date of Enter into Acromegaly Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acromegaly Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Acromegaly Revenue Market Share by Type (2018-2023)
Table 27. Global Acromegaly Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Acromegaly Revenue Market Share by Type (2024-2033)
Table 29. Global Acromegaly Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Acromegaly Revenue Market Share by Application (2018-2023)
Table 31. Global Acromegaly Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Acromegaly Revenue Market Share by Application (2024-2033)
Table 33. North America Acromegaly Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Acromegaly Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Acromegaly Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Acromegaly Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Acromegaly Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Acromegaly Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Acromegaly Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Acromegaly Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Acromegaly Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Acromegaly Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Acromegaly Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Acromegaly Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Acromegaly Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Acromegaly Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Acromegaly Market Size by Country (2024-2033) & (US$ Million)
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Acromegaly Product
Table 51. Novartis Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Aegis Therapeutics Company Detail
Table 54. Aegis Therapeutics Business Overview
Table 55. Aegis Therapeutics Acromegaly Product
Table 56. Aegis Therapeutics Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 57. Aegis Therapeutics Recent Development
Table 58. Chiasma Company Detail
Table 59. Chiasma Business Overview
Table 60. Chiasma Acromegaly Product
Table 61. Chiasma Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 62. Chiasma Recent Development
Table 63. Crinetics Pharmaceuticals Company Detail
Table 64. Crinetics Pharmaceuticals Business Overview
Table 65. Crinetics Pharmaceuticals Acromegaly Product
Table 66. Crinetics Pharmaceuticals Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 67. Crinetics Pharmaceuticals Recent Development
Table 68. Daewoong Pharmaceutical Company Detail
Table 69. Daewoong Pharmaceutical Business Overview
Table 70. Daewoong Pharmaceutical Acromegaly Product
Table 71. Daewoong Pharmaceutical Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 72. Daewoong Pharmaceutical Recent Development
Table 73. Peptron Company Detail
Table 74. Peptron Business Overview
Table 75. Peptron Acromegaly Product
Table 76. Peptron Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 77. Peptron Recent Development
Table 78. Silence Therapeutics Company Detail
Table 79. Silence Therapeutics Business Overview
Table 80. Silence Therapeutics Acromegaly Product
Table 81. Silence Therapeutics Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 82. Silence Therapeutics Recent Development
Table 83. Strongbridge Biopharma Company Detail
Table 84. Strongbridge Biopharma Business Overview
Table 85. Strongbridge Biopharma Acromegaly Product
Table 86. Strongbridge Biopharma Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 87. Strongbridge Biopharma Recent Development
Table 88. Amryt Pharma Company Detail
Table 89. Amryt Pharma Business Overview
Table 90. Amryt Pharma Acromegaly Product
Table 91. Amryt Pharma Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 92. Amryt Pharma Recent Development
Table 93. Foresee Pharmaceuticals Company Detail
Table 94. Foresee Pharmaceuticals Business Overview
Table 95. Foresee Pharmaceuticals Acromegaly Product
Table 96. Foresee Pharmaceuticals Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 97. Foresee Pharmaceuticals Recent Development
Table 98. Glide Pharmaceutical Company Detail
Table 99. Glide Pharmaceutical Business Overview
Table 100. Glide Pharmaceutical Acromegaly Product
Table 101. Glide Pharmaceutical Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 102. Glide Pharmaceutical Recent Development
Table 103. Ionis Pharmaceuticals Company Detail
Table 104. Ionis Pharmaceuticals Business Overview
Table 105. Ionis Pharmaceuticals Acromegaly Product
Table 106. Ionis Pharmaceuticals Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 107. Ionis Pharmaceuticals Recent Development
Table 108. Ipsen Company Detail
Table 109. Ipsen Business Overview
Table 110. Ipsen Acromegaly Product
Table 111. Ipsen Revenue in Acromegaly Business (2018-2023) & (US$ Million)
Table 112. Ipsen Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acromegaly Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acromegaly Market Share by Type: 2022 VS 2033
Figure 3. Somatostatin Analogues Features
Figure 4. Dopamine Agonists Features
Figure 5. Growth Hormone Receptor Antagonists Features
Figure 6. Other Features
Figure 7. Global Acromegaly Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Acromegaly Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Acromegaly Report Years Considered
Figure 12. Global Acromegaly Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Acromegaly Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Acromegaly Market Share by Region: 2022 VS 2033
Figure 15. Global Acromegaly Market Share by Players in 2022
Figure 16. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Acromegaly Revenue in 2022
Figure 18. North America Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Acromegaly Market Share by Country (2018-2033)
Figure 20. United States Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Acromegaly Market Share by Country (2018-2033)
Figure 24. Germany Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Acromegaly Market Share by Region (2018-2033)
Figure 32. China Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Acromegaly Market Share by Country (2018-2033)
Figure 40. Mexico Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Acromegaly Market Share by Country (2018-2033)
Figure 44. Turkey Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Acromegaly Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 47. Aegis Therapeutics Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 48. Chiasma Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 49. Crinetics Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 50. Daewoong Pharmaceutical Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 51. Peptron Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 52. Silence Therapeutics Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 53. Strongbridge Biopharma Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 54. Amryt Pharma Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 55. Foresee Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 56. Glide Pharmaceutical Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 57. Ionis Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 58. Ipsen Revenue Growth Rate in Acromegaly Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed